Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b

Molecular Endocrinology

Volumn 28, Issue 4, 2014, Pages 565-574

  Yang, Xiaosong ^a,b   Wang, Xianfeng ^c   Liu, Dongxu ^a   Yu, Liqing ^d   Xue, Bingzhong ^b,c   Shi, Hang ^b,c  

^a HUBEI UNIVERSITY   (China)

^b GEORGIA STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; SATURATED FATTY ACID; STEARIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR PARAMETERS; CHROMATIN IMMUNOPRECIPITATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; INFLAMMATION; INSULIN SENSITIVITY; MACROPHAGE POLARIZATION; MALE; MOUSE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYROSEQUENCING; SIGNAL TRANSDUCTION; ADIPOCYTE; ANIMAL; C57BL MOUSE; CELL LINE; CELL POLARITY; CYTOLOGY; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; MACROPHAGE; METABOLISM; PATHOLOGY; PROMOTER REGION;

ADIPOCYTES; ANIMALS; CELL LINE; CELL POLARITY; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; INFLAMMATION; INSULIN; MACROPHAGES; MICE; MICE, INBRED C57BL; OBESITY; PPAR GAMMA; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION;

EID: 84897945915     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1293     Document Type: Article

References (48)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444: 860-867.
2. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010; 72: 219-246.
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796-1808.
4. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112: 1821-1830.
5. Fujisaka S, Usui I, Bukhari A, et al. Regulatory mechanisms for adipose tissueM1andM2macrophages in diet-induced obese mice. Diabetes. 2009; 58: 2574-2582.
6. Li P, Lu M, Nguyen MT, et al. Functional heterogeneity of CD11cpositive adipose tissue macrophages in diet-induced obese mice. J Biol Chem. 2010; 285: 15333-15345.
7. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117: 175-184.
8. Wu H, Perrard XD, Wang Q, et al. 1c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2010; 30: 186-192.
9. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes. 2008; 57: 3239-3246.
10. Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010; 299: E1016-E1027.
11. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3: 23-35.
12. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25: 677-686.
13. Bouhlel MA, Brozek J, Derudas B, et al. Unlike PPARγ, PPARα or PPARβ/δ activation does not promote human monocyte differentiation toward alternative macrophages. Biochem Biophys Res Commun. 2009; 386: 459-462.
14. Bouhlel MA, Derudas B, Rigamonti E, et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007; 6: 137-143.
15. Charo IF. Macrophage polarization and insulin resistance: PPARγ in control. Cell Metab. 2007; 6: 96-98.
16. Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008; 7: 485-495.
17. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature. 2007; 447: 1116-1120.
18. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 2008; 7: 496-507.
19. Luczak MW, Jagodziński PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol. 2006; 44: 143-154.
20. Maunakea AK, Chepelev I, Zhao K, Bruneau B. Epigenome mapping in normal and disease States. Circ Res. 2010; 107: 327-339.
21. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008; 9: 465-476.
22. Bäckdahl L, Bushell A, Beck S. Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int J Biochem Cell Biol. 2009; 41: 176-184.
23. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med. 2007; 261: 488-499.
24. Kröger H, Dietrich A, Grätz R, Wild A, Ehrlich W. The effect of tryptophan plus methionine, 5-azacytidine, and methotrexate on adjuvant arthritis of rat. Gen Pharmacol. 1999; 33: 195-201.
25. Ishii M, Wen H, Corsa CA, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009; 114: 3244-3254.
26. Satoh T, Takeuchi O, Vandenbon A, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010; 11: 936-944.
27. Yang Z, Wang X, He Y, et al. The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1. PLoS One. 2010; 7: e49935.
28. Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage α1 AMP-activated protein kinase (α1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 2010; 285: 19051-19059.
29. Shi H, Tzameli I, Bjørbaek C, Flier JS. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem. 2004; 279: 34733-34740.
30. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116: 3015-3025.
31. Fujiki K, Kano F, Shiota K, Murata M. Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol. 2009; 7: 38.
32. Shore A, Karamitri A, Kemp P, Speakman JR, Lomax MA. Role of Ucp1 enhancer methylation and chromatin remodelling in the control of Ucp1 expression in murine adipose tissue. Diabetologia. 2010; 53: 1164-1173.
33. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 2008; 8: 923-934.
34. Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA. Role of theDNAmethyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res. 2004; 2: 62-72.
35. Edwards TM, Myers JP. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect. 2007; 115: 1264-1270.
36. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010; 21: 214-222.
37. Campión J, Milagro FI, Martinez JA. Individuality and epigenetics in obesity. Obes Rev. 2009; 10: 383-392.
38. Holness MJ, Sugden MC. Epigenetic regulation of metabolism in children born small for gestational age. Curr Opin Clin Nutr Metab Care. 2006; 9: 482-488.
39. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009; 58: 2718-2725.
40. Maier S, Olek A. Diabetes: a candidate disease for efficient DNA methylation profiling. J Nutr. 2002; 132: 2440S-2443S.
41. Szarc vel Szic K, Ndlovu MN, Haegeman G, Vanden Berghe W. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem Pharmacol. 2010; 80: 1816-1832.
42. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009; 10: 295-304.
43. Stancheva I. Caught in conspiracy: cooperation between DNA methylation and histone H3K9 methylation in the establishment and maintenance of heterochromatin. Biochem Cell Biol. 2005; 83: 385-395.
44. Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H. The role of DNA methylation in setting up chromatin structure during development. Nat Genet. 2003; 34: 187-192.
45. Lande-Diner L, Zhang J, Ben-Porath I, et al. Role of DNA methylation in stable gene repression. J Biol Chem. 2007; 282: 12194-12200.
46. Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol. 2010; 299: F14-F25.
47. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008; 205: 2409-2417.
48. Brasacchio D, Okabe J, Tikellis C, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009; 58: 1229-1236.